ALKBH5通过降低N6-甲基氨酸甲基化的调节来调节喘进展
Xiang Fan1, Chen Wei2, Yongguang Han3
1Henan University of Chinese Medicine, Zhengzhou, China. 95005016@qq.com.
Iranian journal of allergy, asthma, and immunology
|June 1, 2024
概括
通过增加m6A修饰和GPX4表达,ALKBH5 Knockdown提高支气管上皮细胞存活率,并通过增加m6A修饰和GPX4表达,减少喘模型中的铁亡. 这表明ALKBH5是喘的潜在治疗点.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 喘是一种慢性炎症性呼吸道疾病.
- N6-甲基氨酸甲基化 (m6A) 是疾病中的关键表观遗传调节剂.
- ALKBH5 (alkB同类5) 是一种m6A脱甲基酶,涉及各种病理.
研究的目的:
- 为了研究ALKBH5在调节喘发病过程中的作用.
- 在体外喘模型中探索ALKBH5的潜在分子机制.
主要方法:
- 建立了一个因特乐金-13 (IL-13) 诱导的支气管上皮细胞模型.
- 利用siRNA击败ALKBH5并通过qPCR评估其有效性.
- 测量了细胞活力,增殖和铁灭标志物 (铁,Fe2+,ROS,MDA,SOD).
- 使用MeRIP试验分析了m6A修饰丰富和量化了GPX4表达.
主要成果:
- ALKBH5倒置显著增加了支气管上皮细胞的存活率和增殖.
- 由于ALKBH5的减少,IL-13-诱导的铁亡通过使铁水平正常化,Fe2+,脂质ROS,MDA和SOD.
- Knockdown 的 ALKBH5 提升了 m6A 丰富和增加了谷氨过氧化酶 4 (GPX4) 表达.
- GPX4的淘汰抵消了ALKBH5的淘汰对细胞增殖和铁亡的保护作用.
结论:
- 在喘模型中,ALKBH5 Knockdown促进支气管上皮细胞的增殖,并缓解铁亡.
- 保护作用通过增加m6A修饰和GPX4.4的上调调节来介导.
- ALKBH5成为治疗喘的潜在治疗点.
相关概念视频
Asthma: Pathogenesis and Management
386
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
386
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
249
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
249
Antiasthma Drugs: Methylxanthines
216
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
216
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
271
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
271
Histone Modification
13.2K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.2K


